Retrophin Inc (NASDAQ:RTRX)

22.75
Delayed Data
As of Feb 16
 +0.54 / +2.43%
Today’s Change
15.55
Today|||52-Week Range
26.44
+7.97%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close22.21
Today’s open22.11
Day’s range22.11 - 22.89
Volume277,279
Average volume (3 months)239,582
Market cap$894.2M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+2.71%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.41-2.19%
EDITEditas Medicine Inc-0.97-2.79%
EPZMEpizyme Inc-0.50-2.68%
----
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts